Currently, surgery associated with radiotherapy represents the treatment of choice for breast cancer patients since it can extend their life expectancy and ameliorate prognosis. On occasion, however, such a curative strategy can be complicated with a potentially ominous condition, the so-called secondary cutaneous angiosarcoma of the breast